Here we investigate the mechanisms by which HTLV-1 infection prevents the cell death of CD8 + T cells in vivo. We show that upon natural infection, cloned CD8 + but not CD4 + cells from patients without malignancy become resistant to Fas-mediated cell death and acquire an antiapoptotic transcriptome that includes the overexpression of cIAP-2 and c-FLIP(L). CD8 + lymphocyte-restricted cIAP-2 overexpression correlates with resistance to Fas-mediated apoptosis and depends on tax expression via NF-KappaB. In contrast, in the same CD8 + cells, the HTLV-1-dependent overexpression of c-FLIP(L) does not correlate with resistance to Fas-mediated cell death nor with tax expression. In the present model, infected CD8 + clones are the only cell subtype in which cIAP-2 expression correlates with resistance to cell death. These results support a role for Tax-dependent cIAP-2 expression in preventing the death of naturally infected CD8 + cells and thereby in their clonal expansion in vivo.
Introduction
HTLV-1 is the etiological agent of two different types of diseases: adult T-cell leukemia/lymphoma (ATLL), an aggressive T-cell neoplasm (Uchiyama et al., 1977) , and tropical spastic paraparesis/HTLVassociated myelopathy (TSP/HAM) (Gessain et al., 1985) , a progressive demyelinating disease that targets mainly the thoracic spinal cord. ATLL and TSP/HAM arise in a minority (3-5%) of infected individuals after a latency period ranging from years (TSP/HAM) to decades (ATLL).
Both CD4 + and CD8 + T cells are infected by HTLV-1 in vivo. After a short period of primary infection characterized by a burst of reversetranscription-based replication, a pool of~0.1% to~10-20% of lymphoid cells remains persistently infected (Bangham et al., 2009 ). T-cell clones, in each of which all daughter cells derive from an infected progenitor cell, are thus the main reservoir for HTLV-1 in vivo.
These clones are persistently expanded since they can be regularly detected during the lifespan of infected individuals (Cavrois et al., 1998) . Cells within these clones are selected for their ability to express the HTLV-1 encoded tax gene in vivo (Zane et al., 2010) and display high-level genetic instability, as evidenced by high somatic mutation loads (Mortreux et al., 2001b) . ATLL is the malignant transformation of a persistently expanding CD4 + clone, whereas in TSP/HAM, infected and uninfected CD4 + and CD8 + cells infiltrate and damage the spinal cord (Hara et al., 1994) . We recently investigated the mechanisms underlying the clonal expansion of HTLV-1 infected cells in vivo (Sibon et al., 2006) . To this end we designed an ex vivo model of clonal expansion based on the culture of T cells deriving from infected individuals and cloned through limiting dilution. This permitted to demonstrate that the clonal expansion of HTLV-1 positive CD8 + and CD4 + lymphocytes involves two distinct mechanisms: infection prevents cell death in CD8 + lymphocytes whereas recruiting CD4 + lymphocytes into the cell cycle (Zane et al., 2009 ). The HTLV-1-encoded proteins Tax (Boxus et al., 2008) , p12, and p13 target multiple pathways governing cell death (reviewed in Saggioro et al., 2009 ). Tax enhances cell survival through its effects on the NF-KB (Kawakami et al., 1999; McKinsey et al., 1996) , CREB (Kwok et al., 1996; Virology 407 (2010) Trevisan et al., 2006) and AKT (Kawakami et al., 2007; Liu et al., 2001) pathways and the tumor suppressors p53 (de la Fuente et al., 2003; PiseMasison et al., 1998) and RB (Haller et al., 2002; Kehn et al., 2005) . The accessory protein p13 is targeted to the inner mitochondrial membrane and sensitizes cells to death stimuli involving this organelle (D'Agostino et al., 2005) , such as the Fas/ceramide pathway (Silic-Benussi et al., 2004) and reactive oxygen-species (ROS)-mediated cell death . P12 enhances the release of calcium from the endoplasmic reticulum and therefore may influence calcium-dependent apoptotic signals, including the opening of the mitochondrial permeability pore (Kim et al., 2003) .
Having evidenced that the clonal expansion of infected CD8 + lymphocytes relies on reduced cell death, we aimed at dissecting the mechanisms underlying apoptosis blockade in these cells in vivo. To this end we cloned peripheral blood mononuclear cells (PBMCs) from infected patients without malignancy. This allowed to compare naturally infected CD4 + and CD8 + clones to their uninfected counterparts for resistance to cell death, apoptosis regulation, and gene expression. We first demonstrated that upon infection, cloned CD8 + cells but not CD4 + cells from infected patients without malignancy acquire resistance to Fas-mediated cell death. Results of microarray analyses confirmed by real-time quantitative PCR revealed that only a restricted subset of genes involved in apoptosis is specifically deregulated in infected CD8 + clones deriving from patients. Among these, the two antiapoptotic genes cIAP-2 (cellular inhibitor of apoptosis 2) (Roy et al., 1997) and c-FLIP (FLICE-inhibitory protein) (Krueger et al., 2001 ) were found to be specifically overexpressed in infected CD8 + clones. However, in the present model of clonal expansion, cIAP-2 but not c-FLIP could be linked to the resistance of naturally infected CD8 + clones to apoptosis. This phenomenon was found to be dependent on tax expression via NF-KappaB. Therefore, cIAP-2 seems to be involved in the CD8 + -associated dissemination and persistence of the virus in vivo.
Results

HTLV-1 positive CD8
+ cloned lymphocytes from patients with TSP/HAM resist Fas-mediated cell death HTLV-1 positive cell lines and tax expressing cells resist death receptor-mediated apoptosis (induced by anti-Fas IgM and tumor necrosis factor-related apoptosis-inducing ligand) (Arai et al., 1998; Hamasaki et al., 2001) . Although circulating CD4 + cells from patients with TSP/HAM are known to resist etoposide killing, as compared to CD4 + cells from uninfected controls (Hamasaki et al., 2001) (Fig. 1B) . From these data we concluded that in the present model of clonal expansion, HTLV-1 infection and tax expression trigger the resistance of CD8 + but not that of CD4 + cells to specific Fas-mediated cell death.
Cloned HTLV-1 infected CD8 + cells possess an antiapoptotic transcriptome
Gene dysregulation is the hallmark of HTLV-1 infected cells (Matsuoka and Jeang, 2007 (Fig. 2) . Canonical pathways analysis using the Ingenuity Pathways Analysis (IPA) library identified two apoptotic pathways that were most significant to the data set. They corresponded to the "apoptosis signaling" and "death receptor signaling" pathways defined by the IPA software (Ingenuity Systems, Redwood City, CA). Genes from the data set that met the fold change cutoff of 1.3 (see Materials and methods section) and were associated with these canonical pathways in the Ingenuity Pathways Knowledge Base are represented in Table 1 . Quantitative RTPCR was carried out for 8 of these 13 genes in 7 of the 12 clones analyzed by microarray. Results of qRTPCR and microarrays were consistent in all cases. It is evident from To confirm and extend results from microarray experiments, we next measured the expression of the proapoptotic and antiapoptotic deregulated genes cIAP-2, c-FLIP, N-ras, PRKCQ, FasL, Apo2L, caspase-3, and LMNA by qRTPCR in additional CD4 + and CD8 + infected or uninfected clones tested for gene expression at day 6 from PHA stimulation (39 clones analyzed). c-FLIP has been previously found to possess splicing variants with distinct effects on apoptosis (Chang et al., 2002) . Accordingly, quantitative analysis was made with these two transcripts, i.e. c-FLIP(S) and c-FLIP(L) (Fig. 3) . Quantitative RTPCR analysis revealed a wide variation in gene expression between clones (Fig. 3) , thus explaining why, in contrast to microarray results, only a subset of comparisons reached statistical significance (Fig. 3) . PRKCQ, for instance, was significantly underexpressed upon infection in CD4 + clones while cIAP-2, c-FLIP(L) and LMNA were significantly overexpressed in infected CD8 + clones (Fig. 3) . The expression of the six remaining genes, as measured by qRTPCR, was not significantly different between infected and uninfected CD4 + or CD8 + clones.
Given the differences described, we assumed that the overexpression of cIAP-2, c-FLIP(L) and LMNA best distinguished the effects of infection between CD4 + and CD8 + clones. Interestingly, both cIAP-2 and c-FLIP have recently been found to be overexpressed in tax positive cell lines in which they protect from Fas-mediated cell death (Krueger et al., 2006; Okamoto et al., 2006; Waldele et al., 2006) . Together with the correlation between tax expression and the resistance of CD8 + T cells to Fas-mediated cell death, these qRTPCR findings led us to reconsider, in the present model, the implication of the two genes in vivo in the context of untransformed CD4 + versus CD8 + infection and clonal expansion.
CD8
+ lymphocyte-restricted cIAP-2 overexpression correlates with resistance to Fas-mediated apoptosis and depends on tax expression via NF-KappaB.
CIAP-2 prevents cell death by inhibiting caspases 3, 7, and 9 (Deveraux et al., 1998; Roy et al., 1997) . Its expression parallels that of tax in HTLV-1 positive cell lines (Waldele et al., 2006) while in the HTLV-1 negative Jurkat cell line, ectopic tax expression triggers cIAP-2 expression via NF-Kappa B, resulting in a decreased proportion of sub-G1 cells due to the inhibition of caspases 3 and 7 (Waldele et al., 2006) . Here we found that the level of cIAP-2 expression was significantly higher in infected than in uninfected CD8 + cloned T cells (Fig. 3) . In T-cell clones deriving from patients with TSP/HAM, there was a significant negative correlation between cIAP-2 expression and Fas-mediated apoptosis in infected CD8 + clones (R = −0.5, p = 0.028, Spearman rank correlation) but not in infected CD4 + or in uninfected CD4 + and CD8 + clones. Furthermore, a significant positive correlation was found between tax and cIAP-2 expression in CD8 + (R = 0.708, P = 0.005, Spearman rank correlation) and CD4 + cells (R = 0.779, p = 0.005, Spearman rank correlation). To date, the effect of tax on cIAP-2 expression and function has not been investigated in cells infected by a full-length virus. We therefore explored the link between tax and cIAP-2 expression by expressing tax specific shRNAs using lentiviral vectors in the tax expressing MT4 cells, which harbor full-length integrated proviruses. VSV-G-pseudotyped viruses were produced in 293T cells by cotransfection of the shRNA-containing lentiviral vector backbone with expression plasmids for Gag, Pol, and VSV-G. The same vector expressing a nonsense shRNA was used in parallel for control. Transduction experiments were performed in quadruplicate. The effect of the transduced shRNA on tax and cIAP-2 expressions was analyzed by qRTPCR 60 h after shRNA gene transduction. As shown in Fig. 4A and B, significantly reduced levels of both tax RNA and cIAP-2 mRNA were found in all shRNA-containing cells. Caspase 3 activity is a central event in apoptosis induction (Yuan et al., 1993) and, as such; it allows indirect measurement of apoptosis rates. Since cIAP-2 functions by binding and inhibiting caspase 3 (Deveraux et al., 1998; Roy et al., 1997) , we sought to determine caspase 3 activity. MT4 cells were treated with cIAP-2-specific shRNAs which inhibited cIAP-2 expression (Fig. 4D ). Fig. 4D shows a significant increase of caspase 3 activity in shRNAs-cIAP-2-containing HTLV-1 positive cells. Finally we confirmed that the tax-mediated cIAP-2 expression depended on NF-KappaB in MT4 cells (not shown) as in in vivo infected CD8 + cells. To this end, four CD8 + infected clones exhibiting various amounts of tax mRNA were incubated with the NFKappaB inhibitor LLnL (1 μM) (Matsuda et al., 2005) and then assayed for cIAP-2 expression using qRTPCR. Fig. 5A shows that LLnL decreased cIAP-2 expression in the tax negative CD8 + clone YB33, a result consistent with the known NF-KappaB-dependent transcription of cIAP-2 (Hubinger et al., 2004; Schoemaker et al., 2002) . In tax positive CD8 + clones, LLnL significantly decreased cIAP-2 expression ( genes of the death receptor signaling pathway in infected CD4 + and CD8 + cells versus uninfected CD4 + and CD8 + cells deriving from the same individuals were delineated by oligonucleotide microarray analysis, followed by data analysis and modified graphical display using the Ingenuity Pathway software as detailed in the Materials and methods section (for further information, see also www.ingenuity.com). Gene overexpression is shown in pink, down-regulation in green.
without affecting tax expression (Fig. 5B ). In these tax expressing CD8 + clones, the inhibitory effect of LLnL on cIAP-2 expression increased as a function of tax expression ( Fig. 5B and C) : there was a 30% decrease in cIAP-2 expression between the clones YB-33 and YB-207D which respectively expressed the lowest (0 AU) and the highest (0.88 AU) amounts of tax mRNA. Fig. 5C illustrates the correlation between tax and cIAP-2 expressions in CD8 + HTLV-1 positive clones in the presence (1 μM) or absence of the NF-KappaB inhibitor LLnL. The figure shows that LLnL significantly decreased the slope of the curve, suggesting that in vivo, the tax-dependent expression of cIAP-2 depends on NF-KappaB. This suggests that upon infection, CD8 + lymphocytes specifically overexpress cIAP-2 in a tax-dependent manner via NF-KappaB. From these results we concluded that in the present model, cIAP-2 expression correlates with tax expression and resistance of cloned lymphocytes to receptor-mediated apoptosis in infected CD8 + clones but not in other infected or uninfected cells.
+ lymphocyte-restricted c-FLIP overexpression does not correlate with resistance to apoptosis, yet depends on tax expression in a phenotype-and splice variant-dependent manner c-FLIP is one of the major regulators of Fas-mediated apoptosis at the DISC level (for review see Krueger et al., 2001) . c-FLIP(L), but also c-FLIP (S) have been found to be overexpressed in Tax expressing cell lines (Krueger et al., 2006) . Upon ectopic Tax expression, both resistance to Fas-mediated apoptosis and induction of c-FLIP are dependent on Tax (Krueger et al., 2006; Okamoto et al., 2006) . Here the level of c-FLIP(L) expression was significantly higher in infected than in uninfected CD8 + cloned T cells (Fig. 3) . However, in contrast to cIAP-2 expression, there was no significant correlation between c-FLIP(L) or c-FLIP(S) expressions and Fas-mediated cell death in CD8 + and CD4 
Discussion
For HTLV-1, apoptosis has been mainly investigated for understanding CD4 + T cell transformation (Saggioro et al., 2009 Fig. 2A) . However, upon infection, only a restricted subset of genes was deregulated, with considerable differences between the two cells types (Table 1 and Fig. 3 ). In fact upon infection CD8 + but not CD4 + clones acquired specific gene deregulations consistent with their evidenced apoptosis-resistant phenotype (Sibon et al., 2006; Zane et al., 2009) . Quantitative RTPCR revealed a wide variation of the level of gene expression between clones explaining why only 42% of the differences observed through the microarray analysis of 6 clones (Table 1) persisted after the qRTPCR analysis of 39 clones (Fig. 3) .
Among genes specifically deregulated in infected CD8 + cells, cIAP-2 and c-FLIP were analyzed in more details as they play a major role in blocking apoptosis and have been recently identified as Tax targets in cell lines (Krueger et al., 2006; Okamoto et al., 2006; Waldele et al., 2006) . We confirmed in vitro and evidenced for the first time ex vivo that cIAP-2 expression depends on tax expression via NF-Kappa B and correlates with cell resistance to receptor-mediated cell death in CD8 + but not in CD4 + clones deriving from naturally infected individuals without malignancy. On the contrary, c-FLIP expression was inversely correlated with tax expression in HTLV-1 positive CD8 + cells from patients and did not correlate with resistance to cell death. Therefore one can propose that cIAP-2 expression is important for specifically stimulating infected CD8 + cell expansion in vivo.
Our cellular model of ex vivo clonal expansion selects in vivo persistently expanded clones. We previously demonstrated that after cloning, the proportion of infected CD4 + and CD8 + cloned cells reflects the proviral load in vivo (Sibon et al., 2006) and that cloned HTLV-1 positive cells correspond to persistently infected cells in vivo (Zane et al., 2010) . This suggests that the present strategy does not introduce a significant bias with respect to the persistent clonal expansion that sustains the proviral load in vivo. However we previously evidenced with the BLV system that primary infection generates a huge excess of infected clones and that the number of these significantly decreases over time (Pomier et al., 2008 (Pomier et al., , 2009 ). This suggests that in vivo, primary infection might select for apoptosis-resistant clones that the present strategy is unable to isolate.
Resistance to cell death is the hallmark of HTLV-1 positive or taxexpressing cell lines and depends on tax expression (Arai et al., 1998; Hamasaki et al., 2001 ) while other HTLV-1 accessory proteins also (Sibon et al., 2006; Zane et al., 2009 ). Microarray and qRTPCR analyses of infected and uninfected clones identified a restricted number of genes involved in apoptosis and specifically deregulated in CD8 + T-cell clones. Among these, c-FLIP and cIAP-2 are known to be up regulated by Tax in vitro (Krueger et al., 2006; Okamoto et al., 2006; Waldele et al., 2006) . Given that the effect of these genes has not been investigated in the context of naturally infected CD4 + or CD8 + cells and that in our model resistance of infected CD8 + T cells to cell death correlated with tax expression, we investigated the role of cIAP-2 and c-FLIP in cell death resistance in CD4 + versus CD8 + infected and uninfected cells deriving from patients with TSP/HAM. The interplays between Tax, NF-KappaB and cIAP-2 expressions have been previously evidenced in tax transfected cell lines (Waldele et al., 2006) . As other viral proteins might interfere with tax in gene regulation (Matsuoka and Jeang, 2007) we investigated the effect of Tax on cIAP-2 expression in MT4 cells that carry full-length integrated proviruses and express tax. Tax shRNA reduced cIAP-2 expression in these cells and cIAP-2 down-regulation increased caspase 3 activity. Furthermore, LLnL experiments permitted to link the effect of tax expression on cIAP-2 expression with NF-Kappa B in both MT4 cells and cloned CD8 + T cells from patients. There was no link between cIAP-2 expression and resistance to cell death in uninfected CD4 + and CD8 + cells. Interestingly, although both infected CD4 + and CD8 + clones displayed strong correlations between tax and cIAP-2 expressions in vivo, cIAP-2 expression correlated with Fas-dependent cell death resistance in CD8 + but not in CD4 + infected clones. This suggests that additional phenotype-specific factors might contribute in vivo to triggering cIAP-2-based cell death resistance in HTLV-1 infected lymphocytes. HTLV-1 cell lines express high levels of both c-FLIP(L) and c-FLIP(S) mRNA while the ectopic expression of tax in Jurkat cells augments c-FLIP expression and triggers resistance to Fas-mediated cell death (Krueger et al., 2006) . Microarray analyses of cloned T cells from patients with TSP/HAM were consistent with an overexpression of c-FLIP in both CD4 + and CD8 + infected clones ( (Nagai et al., 2001; Sibon et al., 2006) , virus dissemination (Cavrois et al., 2000; Mortreux et al., 2001a) , impairment of anti-HTLV-1 cellular immune response (Hanon et al., 2000) and tissue damage (Hara et al., 1994) , the present results obtained in naturally infected cells identify cIAP-2 expression as an important target for treating HTLV-1 infection.
Materials and methods
Ethics statement
This study was conducted according to the principles expressed in the Declaration of Helsinki. The study was approved by the Institutional Review Board of the Léon Bérard anticancer center. All patients provided written informed consent for the collection of samples and subsequent analysis.
Samples studied
PBMCs were obtained after informed consent from two patients with TSP/HAM. The HTLV-negative acute lymphoblastic leukemia Tcell line Jurkat and the HTLV-1-transformed T-cell line MT4 were propagated as described (Cavrois et al., 1995; Gabet et al., 2003) .
T-cell limiting dilution cloning
PBMCs were cloned in limiting dilution (0.1 cell per well) in Terasaki plates after removal of adherent cells. The medium used for T lymphocyte culture was RPMI 1640 containing penicillin and streptomycin, sodium pyruvate, non-essential amino acid solution, 2-mercapto ethanol, 10% filtered human AB serum, and 100 U/ml recombinant IL-2 (Chiron Corporation). The medium was Fig. 4 . cIAP-2 expression depends on tax expression and inhibits caspase 3. MT4 cells were transduced with a tax-specific shRNA that decreased both tax (A) and cIAP-2. (B) When compared with the control shRNA, the 3 cIAP-2-specific ShRNAs TRC3775, TRC3776, and TRC3777 decreased cIAP-2 expression (C) and increased caspase 3 activity (D). Data shown are the means (±standard deviation) of one representative experiment performed in quadruplicate.
supplemented with 1 μg/ml PHA (Abbott Murex HA 16) and 5 × 10 5 /ml irradiated (30 Gy) allogeneic PBMCs (feeder cells) for cloning. The Terasaki plates were stored at 37°C for 10 days in aluminum foil, then screened for growing cells under the microscope. Positive cultures were transferred to 96-well U-bottom plates in the medium used for culture and restimulated after a few days. T lymphocytes were restimulated every 14 days with PHA (1 μg/ml) and fresh feeder cells (10 6 /ml). Lethally irradiated PBMCs from three distinct allogeneic HTLV-I negative donors were used as feeder cells to exclude the possibility of clones becoming infected in vitro. Cloning efficiency was similar to previous studies and ranged from 20% to 98% (Hafler et al., 1988; Richardson et al., 1997; Sibon et al., 2006; Wucherpfennig et al., 1992) . To preserve the original growth characteristics of the cells, clones were maintained for no more than 4 months, and then fresh aliquots were thawed.
Phenotypic determination
Antibodies recognizing CD4 and CD8 were purchased from DakoCytomation. For fluorescence-activated cell scanner (FACScan) analysis, PBMCs or cloned T cells were incubated with 5% filtered human serum, then stained with antibodies. Staining and scanning were performed in phosphate-buffered saline with 2% fetal calf serum. Isotype-matched controls were used. Data were acquired on a FACScan and analyzed by means of CellQuest™ software (Becton Dickinson).
Apoptosis assay
Apoptosis was assessed by using the APOPTEST™ kit (DakoCytomation) containing fluorescein-conjugated annexin V, propidium iodide and binding buffer. Cells suspended in the binding buffer were mixed with fluorescein-conjugated annexin V and propidium iodide, incubated for 10 min, then analyzed by FACScan. By combining annexin V/FITC and propidium iodide, three distinct phenotypes could be discriminated: non-apoptotic live cells remained unlabeled, apoptotic cells were labeled by annexin V/FITC, and necrotic cells (necrosis or late apoptosis) were labeled by both annexin V/FITC and propidium iodide (PI). For each sample analyzed, this allowed to characterized the cells as viable (AnnV . After apoptosis induction with 1 or 5 μg/ml of agonistic anti-Fas antibody (clone CH11, Upstate Millipore) or 100 or 250 ng/ml of recombinant human FasL (Axxora Alexis Biochemicals) for 24 h, the cells were analyzed for annexin-V positivity. Specific apoptosis was calculated as follows: (% experimental apoptosis −% spontaneous apoptosis)/(100 −% spontaneous apoptosis) ×100. Caspase-3 activity was measured by using the Caspase-3 Fluorometric Assay Kit from Gentaur which utilizes the DEVD-AFC substrate. Activity was determined according to the manufacturer's instructions.
Lentiviral transduction of shRNA
Double-stranded oligonucleotides encoding short hairpin RNAs (shRNAs) specific for tax were ligated into the pLKO.1 vector digested by AgeI and EcoRI restriction enzymes (tax oligonucleotides (target sequence: 541-559 bp of the pX region): CCGGGCCTTCCTCAC-CAATGTTCCTCGAGACATTGGTGAGGAAGGCTTTTTG and AATT-CAAAAAGCCTTCCTCACCAATGTTCTCGAGGAACATTGGTGAGGAAGGC). The shRNA vectors against cIAP-2 (TRC3775-3779), the TurboGFP (SHC003) and non-target shRNA control (SHC002) vectors were purchased from Sigma (Mission TRC shRNA Target Set). Vesicular stomatitis virus-glycoprotein (VSV-G)-pseudotyped lentiviruses were produced in HEK293T cells. For each 10-cm dish, 13.2 μg of lentiviral pLKO vector (expressing TurboGFP or shRNAs against tax, cIAP-2 or a non-target shRNA), 10.2 μg of pCMV8.91, and 2.64 μg of pHCMVG expression plasmids were transfected using CalPhos mammalian transfection kit (Clontech) in the presence of 25 μM chloroquine (Sigma). After 2 days, the lentivirus-containing supernatant was collected and filtered through 0.45 μm syringe filters. For infection, 1.5 × 10 6 lymphocytes were incubated with the media at a vector particle concentration of 200 ng p24/ml for 10 h in the presence of 5 μg/ml polybrene (Sigma), followed by fresh media for 48 h. Lentivirally transduced lymphocytes were harvested for RNA analysis and apoptosis assays.
RNA amplification
RNA amplification and microarray analysis have been performed in the genomic platform ProfileXpert (ProfileXpert, Bron, France). Total RNA was extracted from three CD4 + and three CD8 + infected clones and from three CD4 + and CD8 + uninfected clones using an RNeasy minikit (Qiagen, Hilden, Germany), including a DNAse treatment and according to the manufacturer's protocol. Total RNA yield was measured by OD260, with an A260/A280 ratio of 1.9-2.1 demonstrating purity. Quality was evaluated on nanochips with the Agilent 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA), according to the manufacturer's protocol. Total RNA (50 ng) was then amplified and biotin-labeled by two rounds of in vitro transcription (dIVT) with a Message Amp aRNA kit (Ambion, Austin, TX, USA) following the manufacturer's protocol. Before amplification, different concentrations (1/1000 to 1/1,000,000) of synthetic bacterial mRNA provided in the codelink control RNA spikes kit (Applied Microarrays, Tempe, AZ, USA) were added at a 1:20,000 mass ratio to all samples; these positive controls were used to ascertain the quality of the process. aRNA yield was measured with an UV spectrophotometer and the quality on nanochips with the Agilent 2100 Bioanalyzer (Agilent).
Array hybridization and processing
Ten micrograms of biotin-labeled aRNA was fragmented using 5 μl of fragmentation buffer in a final volume of 20 μl, then mixed with 240 μl of Amersham hybridization solution (GE Healthcare Europe GmbH, Freiburg, Germany) and injected onto CodeLink Uniset Human Whole Genome (CLUHWG) bioarrays containing 55,000 human oligonucleotide gene probes (GE Healthcare Europe GmbH). Arrays were hybridized overnight at 37°C with shaking at 300 rpm in an incubator. The slides were washed in stringent TNT buffer at 46°C for 1 h, then a streptavidin-cy5 (GE Healthcare) detection step was performed. Each slide was incubated for 30 min in 3.4 ml of streptavidin-cy5 solution as described previously (Fèvre-Montange et al., 2006) then washed four times in 240 ml of TNT buffer, rinsed twice in 240 ml of water containing 0.2% Triton X-100, and dried by centrifugation at 600 rpm. The slides were scanned using a Genepix 4000B scanner (Axon, Union City, USA) and Genepix software, with the laser set at 635 mm, the laser power at 100%, and the photomultiplier tube voltage at 60%. The scanned image files were analyzed using CodeLink expression software, version 4.0 (GE Healthcare), which produces both raw and normalized hybridization signals for each spot on the array.
Microarray data analysis
The relative intensity of the raw hybridization signal on arrays varies with the experiments. CodeLink software was therefore used to normalize the raw hybridization signal on each array to the median of the array (median intensity was 1 after normalization) for better cross-array comparison. The threshold of detection was calculated using the mean ± 3 SD of normalized signal intensity of the 100 negative control samples in the array; spots with signal intensities below this threshold are referred to as "absent". Quality of processing was evaluated by generating scatter plots of positive signal distribution. Signal intensities were then converted to log base 2 values. For microarray data, statistical comparison and filtering were performed using Genespring software 7.3.1 (Agilent Polymerase chain reaction analysis T-cell clones were screened for HTLV-I proviral DNA by polymerase chain reaction (PCR) amplification with LTR-specific primers, as previously described (Saito et al., 1996) . The monoclonality of cultured cells was assessed on DNA by TCR-gamma chain gene rearrangement analysis as previously described (Delfau-Larue et al., 2000) . Briefly, all Vg-Jg combinations were amplified in a multiplex PCR. PCR products were run on a denaturating gradient gel. A PCR performed from a monoclonal culture produced one (monoallelic) or two bands (biallelic). Each clone could be identified by its DGGE migration pattern. For real-time quantitative reverse transcriptasepolymerase chain reaction (qRTPCR), total cellular RNA from samples was isolated using TriZol reagent according to the manufacturer's instructions (Invitrogen Life technologies). Before reverse transcription, RNA was treated by DNase (Invitrogen) to prevent DNA contamination. First-strand cDNA was synthesized from 0.5 mcg RNA using random primers (Promega) and Superscript II reverse transcriptase (Invitrogen). RNA concentration and purity were determined by UV spectrophotometry (nanodrop). The primer pairs and probes were designed using the Universal Probe Library website (Roche diagnostics). The primers of each pair were located in different exons to avoid genomic amplification. Primer and probe sequences for tax (Yamano et al., 2002) and FasL were found in the literature (Bolstad et al., 2003) . HPRT-1 was used as the reference gene for the normalization of results. PCRs were performed using LightCycler Taqman Master (Roche Applied Science, Basel, Switzerland) on a LightCycler 2.0 system (Roche Applied Science, Basel, Switzerland). The reaction mixture contained 2 μl of a 1/10 dilution of first-strand cDNA from cells, 4 μl of LightCycler TaqMan Master Mix 5× (containing FastStart TaqDNA polymerase, reaction buffer, deoxynucleoside triphosphate mixture, MgCl2), 2 μl of primers and probe (primers were used at 2 mcM and probe at 1 μM concentrations; 5 and 4 μM for tax). The final reaction volume was 20 μl. Thermocycling conditions involved three consecutive steps (the thermocycling conditions of the Roche Applied Science Universal Probe Library were used for the reference genes).
Step 1: denaturation and polymerase activation by 10 min heating at 95°C prior to amplification.
Step 2 (45 cycles): denaturation for 10 s at 95°C, annealing for 30 s at 60°C and extension for 1 s at 72°C.
Step 3: cooling for 30 s at 40°C for one cycle. A large amount of cDNA was prepared from the MT4 cell line prior to the experiment. This cDNA was 10 fold-diluted, aliquoted and used as a calibrator for all RT-PCR runs. For relative quantification and normalization, the comparative Ct (or Eff-DDC) method was used (Livak and Schmittgen, 2001 ).
